These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 97392)

  • 1. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
    Wiltrout RH; Frost P; Cummings GD
    J Natl Cancer Inst; 1978 Jul; 61(1):183-8. PubMed ID: 97392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
    Wiltrout RH; Gorelik E; Brunda MJ; Holden HT; Herberman RB
    Cancer Immunol Immunother; 1983; 14(3):172-9. PubMed ID: 6404550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements of cell-mediated cytotoxicity on target cells labelled with the indium-111-oxine complex.
    Smet-Donnay M; Guillaume M; Schaaf-Lafontaine N; Czichosz R; Firket H
    Ann Biol Clin (Paris); 1985; 43(3):285-8. PubMed ID: 3161437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of indium-111 for studies of cytotoxicity mediated by lymphocytes or by antibodies and complement.
    Ferluga J; Allison AC; Thakur ML
    J Clin Lab Immunol; 1979 Feb; 1(4):339-42. PubMed ID: 501729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 11 indium-oxine.
    Wiltrout RH; Taramelli D; Holden HT
    J Immunol Methods; 1981; 43(3):319-31. PubMed ID: 6788853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An isotope release cytotoxicity assay applicable to human tumors: the use of 111indium.
    Frost P; Wiltrout R; Maciorowski Z; Rose NR
    Oncology; 1977; 34(3):102-4. PubMed ID: 917438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of clone formation as an assay for T cell-mediated cytotoxicity: short-term kinetics and comparison with 51Cr release.
    Lees RK; MacDonald HR; Sinclair NR
    J Immunol Methods; 1977; 16(3):233-44. PubMed ID: 406330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified 51Cr release assay for cytotoxic lymphocytes.
    Dunkley M; Miller RG; Shortman K
    J Immunol Methods; 1974 Dec; 6(1-2):39-51. PubMed ID: 4215833
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 75Se-release: a short and long term assay system for cellular cytoxicity.
    Leibold W; Bridge S
    Z Immunitatsforsch Immunobiol; 1979 Mar; 155(4):287-311. PubMed ID: 463182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells.
    Holden HT; Oldham RK; Ortaldo JR; Herberman RB
    J Natl Cancer Inst; 1977 Mar; 58(3):611-22. PubMed ID: 839557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indium-III: a new radionuclide label for studying human platelet kinetics.
    Heaton WA; Davis HH; Welch MJ; Mathias CJ; Joist JH; Sherman LA; Siegel BA
    Br J Haematol; 1979 Aug; 42(4):613-22. PubMed ID: 476012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111Indium labeling of cultured human tumor cells.
    Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
    Oncology; 1985; 42(5):322-7. PubMed ID: 3929199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
    Wierda WG; Mehr DS; Kim YB
    J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell mediated lympholysis; a modified technique using 111indium-oxine-labelled targets.
    Jakubek P; Thorsby E; Hirschberg H
    J Immunol Methods; 1983 Jun; 60(3):379-90. PubMed ID: 6406608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enzyme-release assay for natural cytotoxicity.
    Korzeniewski C; Callewaert DM
    J Immunol Methods; 1983 Nov; 64(3):313-20. PubMed ID: 6199426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a P815-derived line with an amplified adenosine deaminase gene: an improved target for cellular cytotoxicity.
    Vielh P; Castellazzi M
    Eur J Immunol; 1985 Oct; 15(10):981-5. PubMed ID: 3932081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.